Braun Stacey Associates Inc Amgen Inc Transaction History

Braun Stacey Associates Inc

$2.49 Billion
Q4 2024

A detailed history of Braun Stacey Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Braun Stacey Associates Inc holds 41,894 shares of AMGN stock, worth $13.1 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

41,894

Previous 54,177 22.67%

Holding current value

$13.1 Million

Previous $17.5 Million 37.45%

% of portfolio

0.44%

Previous 0.69%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$258.78 - $328.31 $3.18 Million - $4.03 Million	-12,283 Reduced 22.67%	41,894 $10.9 Million
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $482,942 - $526,650	1,561 Added 2.97%	54,177 $17.5 Million
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $543,629 - $660,652	-2,069 Reduced 3.78%	52,616 $16.4 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $2.48 Million - $2.99 Million	9,220 Added 20.28%	54,685 $15.5 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $11.6 Million - $13.1 Million	45,465 New	45,465 $13.1 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $44,892 - $50,630	-200 Reduced 6.9%	2,700 $609,000
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $669,059 - $744,546	2,900 New	2,900 $706,000
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $1.78 Million - $2.08 Million	-10,664 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$180.87 - $203.88 $162,963 - $183,695	901 Added 9.23%	10,664 $2.03 Million
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $1.74 Million - $2.03 Million	9,763 New	9,763 $1.9 Million

Others Institutions Holding AMGN

# of Institutions

3,173

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Account

Braun Stacey Associates Inc Amgen Inc Transaction History